Description: MONDAY, Sept. 24 (HealthDay News) -- Prostate cancer prevention studies conducted since the 1990s are poised to revolutionize the field in the next five years, a Canadian analysis concludes.

"I am optimistic that for the coming generation, beginning with men in their 20s and 30s, we will have a viable strategy to decrease the chance of developing prostate cancer later in life," said study lead author Dr. Neil Fleshner.

A professor of surgery, Fleshner heads the division of urology at Princess Margaret Hospital, part of the University Health Network at the University of Toronto.

His team's overview of the last 15 years of prostate cancer prevention research is published in the Nov. 1 issue of Cancer.

According to the U.S. National Cancer Institute (NCI), cancer of the prostate is the most common non-skin cancer among American men. Most patients diagnosed with the disease do not ultimately die of it. However, because of its high prevalence, prostate cancer remains the third b